Diagnostics

Managing CRE: From Diagnosis to Outbreak Management

  • Posted: October 31, 2017
  • |
  • Provided By:

Although rarely reported a decade ago, carbapenem-resistant Gram-negative bacteria, such as Enterobacteriaceae and Pseudomonas aeruginosa, are rapidly spreading, with the risk that they may evolve from multi-drug to pan-drug resistance.

Carbapenem-resistant Enterobacteriaceae (CRE) infections caused by the production of a highly transmissible carbapenemase enzyme are of particular concern. Early identification of carbapenemase-producers is critical to prevent the spread of infection and carbapenem resistance – and it is essential to screen both infected patients and carriers.

This educational booklet provides practical guidance for the diagnosis, screening, infection control and prevention, outbreak management and treatment of these highly-resistant infections.

Created by bioMérieux in collaboration with two leading Antibiotic Resistance experts, this practical guide is intended to inform Infection Preventionists and support implementation of good management practices for CRE infections in healthcare facilities.

Sponsored by Biomérieux

To download the PDF of the ‘Managing CRE: From Diagnosis to Outbreak Management’ educational booklet, please provide us with your contact information.